Trial Phase
Trial Status
Paid Participation
Clear All
20 Sutent Trials Near You
Power is an online platform that helps thousands of patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerTrial Details
Key Eligibility Criteria
54 Participants Needed
CGT9486 + Sunitinib for GIST
Trial Details
Key Eligibility Criteria
442 Participants Needed
Trial Details
Key Eligibility Criteria
453 Participants Needed
Trial Details
Key Eligibility Criteria
1069 Participants Needed
Pembrolizumab + Sunitinib for Thymic Cancer
Trial Details
Key Eligibility Criteria
30 Participants Needed
Targeted Therapy for Advanced Stage Cancer
Trial Details
Key Eligibility Criteria
4200 Participants Needed
XL092 + Nivolumab vs Sunitinib for Kidney Cancer
Trial Details
Key Eligibility Criteria
291 Participants Needed
Nivolumab + Cabozantinib for Kidney Cancer
Trial Details
Key Eligibility Criteria
701 Participants Needed
Sutetinib for Non-Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
99 Participants Needed
Targeted Cancer Drugs for Cancer
Trial Details
Key Eligibility Criteria
720 Participants Needed
Immunotherapy for Advanced Rare Cancers
Trial Details
Key Eligibility Criteria
137 Participants Needed
Savolitinib vs. Sunitinib for Kidney Cancer
Trial Details
Key Eligibility Criteria
60 Participants Needed
Sunitinib vs Cediranib for Sarcoma
Trial Details
Key Eligibility Criteria
34 Participants Needed
Savolitinib + Durvalumab vs. Sunitinib for Kidney Cancer
Trial Details
Key Eligibility Criteria
148 Participants Needed
Sunitinib + Lutathera for Pancreatic Cancer
Trial Details
Key Eligibility Criteria
24 Participants Needed
Sunitinib for Cancer
Trial Details
Key Eligibility Criteria
10 Participants Needed
Bezuclastinib + Sunitinib for GIST
Trial Details
Key Eligibility Criteria
40 Participants Needed
Sutetinib for Non-Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
66 Participants Needed
Sunitinib + Valproic Acid for Uveal Melanoma
Trial Details
Key Eligibility Criteria
210 Participants Needed
Losartan + Sunitinib for Osteosarcoma
Trial Details
Key Eligibility Criteria
41 Participants Needed
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.